526 related articles for article (PubMed ID: 20943333)
1. Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.
Lambrinoudaki I
Maturitas; 2011 Jan; 68(1):13-6. PubMed ID: 20943333
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
3. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
6. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
Moran L; Teede H
Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
[TBL] [Abstract][Full Text] [Related]
7. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
8. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Kazani A; Kolyviras A; Stellos K; Panoulis K; Alexandrou A; Creatsa M; Papamichael C; Lambrinoudaki I
J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
[TBL] [Abstract][Full Text] [Related]
9. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
Talbott EO; Zborowskii JV; Boudraux MY
Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
[TBL] [Abstract][Full Text] [Related]
10. Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?
Daskalopoulos GN; Karkanaki A; Karagiannis A; Mikhailidis DP; Athyros VG
Angiology; 2011 May; 62(4):285-90. PubMed ID: 21474465
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular health in women with polycystic ovary syndrome.
Sukalich S; Guzick D
Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and polycystic ovary syndrome.
Galluzzo A; Amato MC; Giordano C
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
16. [Polycystic ovarian syndrome and diabetes].
Carlsen SM; Salvesen KA; Vanky E; Fougner KJ
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2619-21. PubMed ID: 16215603
[TBL] [Abstract][Full Text] [Related]
17. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
Nardo LG; Patchava S; Laing I
Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
[TBL] [Abstract][Full Text] [Related]
19. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
Srikanthan P; Korenman S; Davis S
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
